| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 160.54B | 169.33B | 184.44B | 188.51B | 166.70B | 113.28B |
| Gross Profit | 21.20B | 22.08B | 25.16B | 26.06B | 19.80B | 13.85B |
| EBITDA | 10.71B | 11.52B | 15.05B | 16.61B | 9.46B | 5.09B |
| Net Income | 5.08B | 5.70B | 8.90B | 10.23B | 4.82B | 2.35B |
Balance Sheet | ||||||
| Total Assets | 148.85B | 149.15B | 152.09B | 148.79B | 143.62B | 122.98B |
| Cash, Cash Equivalents and Short-Term Investments | 15.47B | 15.35B | 16.49B | 16.77B | 15.77B | 18.33B |
| Total Debt | 8.92B | 9.45B | 9.87B | 10.74B | 16.21B | 6.87B |
| Total Liabilities | 42.04B | 42.33B | 47.53B | 51.92B | 54.68B | 38.62B |
| Stockholders Equity | 106.80B | 106.81B | 104.55B | 96.86B | 88.93B | 84.36B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.99B | 1.35B | 9.28B | -11.29B | 779.00M |
| Operating Cash Flow | 0.00 | 7.38B | 5.15B | 13.01B | -8.76B | 4.12B |
| Investing Cash Flow | 0.00 | -4.88B | -2.30B | -3.46B | -2.31B | -2.65B |
| Financing Cash Flow | 0.00 | -3.63B | -3.14B | -8.54B | 8.39B | -1.68B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥349.33B | 12.83 | ― | 3.26% | -7.77% | 58.84% | |
74 Outperform | ¥406.61B | 9.05 | 6.16% | 2.99% | -0.02% | -40.45% | |
74 Outperform | ¥239.21B | 14.50 | 6.87% | 5.25% | -1.43% | 171.44% | |
73 Outperform | ¥175.38B | 7.83 | 7.36% | 3.42% | -18.72% | -25.26% | |
70 Outperform | ¥103.74B | 10.61 | ― | 3.70% | -3.06% | 1.15% | |
64 Neutral | ¥33.89B | -185.54 | ― | 5.02% | -13.64% | -45.74% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |